Targeting the mTOR Pathway Uncouples the Efficacy and Toxicity of PD-1 Blockade in Renal Transplantation

Nature Communications - United Kingdom
doi 10.1038/s41467-019-12628-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway

Forum on Immunopathological Diseases and Therapeutics
BiochemistryBiotechnologyGeneticsMolecular Medicine
2015English

PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond

Cancer immunology research
Cancer ResearchImmunology
2014English

Targeting the PD-1 Pathway in MSI-Stable Metastatic Colorectal Cancer

Chemotherapy: Open Access
2017English

Targeting the Akt/mTOR Pathway in Brca1-Deficient Cancers

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Targeting the PD-1 Pathway: A Promising Future for the Treatment of Melanoma

Archives of Dermatological Research
DermatologyMedicine
2014English

Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway

Surgical Oncology Clinics of North America
SurgeryOncology
2013English

Harnessing the PD-1 Pathway in Renal Cell Carcinoma: Current Evidence and Future Directions

BioDrugs
MedicineBiotechnologyPharmacology
2014English

PD-1 Checkpoint Blockade in Combination With an mTOR Inhibitor Restrains Hepatocellular Carcinoma Growth Induced by Hepatoma Cell-Intrinsic PD-1

Hepatology
MedicineHepatology
2017English

Targeting the PI3K/Akt/mTOR Signalling Pathway in Cystic Fibrosis

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy